Search Within

Beatrice Fregonese

Formats
  1. Meeting Abstract (46)
  2. Journal Article (4)
Groups
  1. Radiation Oncology, Department of (50)
  2. Survivorship Research (50)
  3. Graduate Medical Education (45)
  4. GME, Radiation Oncology (44)
  5. Department of Medicine (26)
  6. Hematologic Malignancies, Division of (26)

More Groups

People
  1. Joachim Yahalom (50)
  2. Brandon Imber (49)
  3. Carla Hajj (37)
  4. Harper Hubbeling (22)
  5. Jisun Lee (21)
  6. Alexandra Dreyfuss (19)

More People

Years
  1. 2025 (2)
  2. 2024 (18)
  3. 2023 (23)
  4. 2022 (6)
  5. 2021 (1)
Publications
  1. Blood (16)
  2. International Journal of Radiation Oncology, Biology, Physics (14)
  3. Hematological Oncology (11)
  4. Blood Advances (2)
  5. Neuro-Oncology (2)
  6. Radiotherapy and Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. Elsevier Inc. (16)
  3. Wiley Blackwell (11)
  4. Oxford University Press (2)
  5. American Association for Cancer Research (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (50)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: An ILROG multicenter study
    Journal Article

    Yegya-Raman, N.; Plastaras, J. P.; Wright, C. M.; Chelius, M.; Zhang, S.; Baron, J. A.; Hubbeling, H.; Sim, A. J.; Robinson, T. J.; Jain, M. D.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Management approaches for primary hepatic lymphoma: 10 year institutional experience with comprehensive literature review
    Journal Article

    Ma, J.; Daou, R.; Bou Eid, J.; Fregonese, B.; El-Khoury, J.; Wijetunga, N. A.; Imber, B. S.; Yahalom, J.; Hajj, C.
    Frontiers in Oncology (2025)

    Fulltext@MSK | Save
  • Bridging radiotherapy may decrease inflammation prior to CAR-T cell therapy
    Meeting Abstract

    Patel, R. R.; Tward, A.; Fregonese, B.; Hubbeling, H.; Lapen, K.; Mankuzhy, N. P.; Raj, S. S.; Perales, M. A.; Shouval, R.; Yahalom, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study
    Meeting Abstract

    Dreyfuss, A.; Ganesan, N.; Alencar, A. J.; Boardman, A. P.; Caron, P.; Chang, T.; Davey, T.; David, K. A.; Dogan, A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Very low dose radiotherapy (VLDRT) with 4 Gy for potentially-curable indolent non-Hodgkin lymphomas
    Meeting Abstract

    Mankuzhy, N. P.; Imber, B. S.; Pammer, P.; Fregonese, B.; Cajo, A.; Cederquist, G.; Dreyfuss, A.; Lapen, K.; Patel, R. R.; Moore, Z. R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Radiation therapy in a new era of multiple myeloma management: Trends of engagement and radiologic, biochemical, and cytogenetic correlates of outcomes and response
    Meeting Abstract

    Dreyfuss, A.; Fregonese, B.; Usmani, S. Z.; Mailankody, S.; Imber, B. S.; Yahalom, J.
    Blood (2024)

    Fulltext@MSK | Save
  • Radiation therapy for Burkitt lymphoma: Multi-decade insights from a single center
    Meeting Abstract

    Tward, A.; Patel, R. R.; Isgor, I.; Galera, P.; Lopez, K.; Fregonese, B.; Moore, Z.; Wolden, S.; Yahalom, J.; Imber, B. S.
    Blood (2024)

    Fulltext@MSK | Save
  • Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Patterns of intracranial response and relapse after CNS-directed radiotherapy (CNS-RT) for patients with chemorefractory or progressive secondary CNS lymphoma (SCNSL)
    Meeting Abstract

    Cederquist, G.; Tringale, K.; Hajj, C.; Moore, Z.; Hubbeling, H.; Dreyfuss, A.; Fregonese, B.; Falchi, L.; Scordo, M.; Grommes, C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save